Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ZIOPHARM Oncology Inc (NASDAQ:ZIOP)

7.79
Delayed Data
As of 4:00pm ET
 +0.40 / +5.41%
Today’s Change
4.56
Today|||52-Week Range
14.93
-6.26%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Belbel Caesar J
Sale11/19/2015153,333$12.84$2.0M-42.49%
Cooper Laurence James Neil
Chief Executive Officer
Sale5/05/2016116,667$6.86$800.3K+7.88%
Lebel Francois /ziopharm/
Executive Vice President-Research & Development
Sale6/09/201550,000$10.12$506.0K-26.98%
Belbel Caesar J
Buy11/19/2015153,333$2.30$352.7K-42.49%
Brennan Murray F
Director
Sale6/03/201534,163$9.72$332.1K-23.34%
Lafond Kevin G
Sale6/03/201527,500$9.70$266.8K-23.34%
Lafond Kevin G
Sale6/03/201526,666$9.60$256.0K-23.34%
Lebel Francois /ziopharm/
Executive Vice President-Research & Development
Buy6/09/201550,000$4.34$217.0K-26.98%
Weiser Michael
Director
Sale4/19/201610,751$8.88$95.5K-16.78%
Fowler Wyche Jr
Director
Sale4/04/201611,694$7.92$92.6K-6.69%
Page of 4